Paper

Clinical efficacy of the co-administration of Turmeric and Black seeds (Kalongi) in metabolic syndrome - a double blind randomized controlled trial - TAK-MetS trial.

Published Apr 1, 2015 · F. Amin, Najmul Islam, N. Anila

Complementary therapies in medicine

114

Citations

Influential Citations

Abstract

Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.

RCTHighly Cited

Study Snapshot

Co-administration of 60% of individual herbs, Turmeric and Black seeds, significantly improves metabolic syndrome parameters with minimal adverse effects.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Clinical efficacy of the co-administration of Turmeric and Black seeds (Kalongi) in metabolic syndrome - a double blind randomized controlled trial - TAK-MetS trial.

References

Citations